Step Therapy Programs for Members on the Oklahoma Performance Full Drug List
Describes step therapy programs applied to multiple prescription drug categories on the Oklahoma Performance Full Drug List and explains exception review process for drugs not on the list. Lists example drugs within categories subject to step therapy.
Lists example drugs by therapeutic category that may be subject to step therapy on the Oklahoma Performance Full Drug List.
Summary of changes and scope
This bulletin notifies members and providers that step therapy programs apply to drugs on the Oklahoma Performance Full Drug List. Example therapeutic categories subject to step therapy include Atopic Dermatitis, Atypical Antipsychotics, Depression, Gabapentin ER, and Kerendia. Third-party brand names are acknowledged and are the property of their respective owners. These lists and programs are subject to change and additional drugs may be added.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.